HEALTHDYNE INFORMATION ENTERPRISES INC
S-8, 1998-05-08
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Previous: HEALTHDYNE INFORMATION ENTERPRISES INC, S-8, 1998-05-08
Next: HEALTHDYNE INFORMATION ENTERPRISES INC, S-8, 1998-05-08



<PAGE>   1
       As filed with the Securities and Exchange Commission on May 8, 1998

                                                    Registration No. *333-
================================================================================

                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                    FORM S-8

                          REGISTRATION STATEMENT UNDER
                           THE SECURITIES ACT OF 1933

                    HEALTHDYNE INFORMATION ENTERPRISES, INC.
             (Exact name of registrant as specified in its charter)

                Georgia                                     58-2112366
     (State or other jurisdiction of                     (I.R.S. Employer
      incorporation or organization)                    Identification No.)

1850 Parkway Place, Suite 1100, Marietta, GA                   30067
  (Address of principal executive offices)                   (Zip Code)

                    HEALTHDYNE INFORMATION ENTERPRISES, INC.
                         RESTATED STOCK OPTION PLAN TWO
                            (Full title of the plan)

                                Joseph G. Bleser
              Executive Vice President and Chief Financial Officer
                    Healthdyne Information Enterprises, Inc.
                         1850 Parkway Place, Suite 1100
                             Marietta, Georgia 30067
                     (Name and address of agent for service)

                                 (770) 423-8450
          (Telephone number, including area code, of agent for service)

        The Commission is requested to mail signed copies of all orders,
                         notices and communications to:

                            PATRICIA A. WILSON, ESQ.
                              TROUTMAN SANDERS LLP
                     600 PEACHTREE STREET, N.E., SUITE 5200
                           ATLANTA, GEORGIA 30308-2216
                                 (404) 885-3242

<TABLE>
<CAPTION>
- -----------------------------------------------------------------------------------------------------------------
                                       CALCULATION OF REGISTRATION FEE
- -----------------------------------------------------------------------------------------------------------------
                                                  Proposed maximum          Proposed maximum         Amount of
  Title of securities        Amount to be          offering price               aggregate          registration
   to be registered         registered (1)          per share (2)          offering price (2)           fee
- -----------------------------------------------------------------------------------------------------------------

<S>                         <C>                   <C>                      <C>                     <C>
Common Stock, $.01 par
value per share,      
together with
associated preferred
stock purchase rights        89,783 shares              $3.54                   $317,832                $94
- -----------------------------------------------------------------------------------------------------------------
</TABLE>

(1)      Pursuant to Rule 416(a) under the Securities Act of 1933, as amended,
         includes an indeterminate number of additional shares which may be
         offered and issued to prevent dilution resulting from stock splits,
         stock dividends or similar transactions as provided in the Healthdyne
         Information Enterprises, Inc. Restated Stock Option Plan Two.

(2)      Estimated solely for the purpose of calculating the registration fee
         pursuant to Rule 457 under the Securities Act of 1933, as amended, on
         the basis of the average of the high and low prices of the Common Stock
         on May 1, 1998 as reported on the Nasdaq National Market.

================================================================================
* As permitted by Rule 429 under the Securities Act of 1933, as amended, the
prospectus related to this Registration Statement also covers securities
registered under Registration Statement No. 333-08279 on Form S-8.


<PAGE>   2


                                EXPLANATORY NOTE

         This Registration Statement on Form S-8 is being filed to register
89,783 additional shares of the common stock, par value $.01 per share, together
with associated preferred stock purchase rights (the "Common Stock"), of
Healthdyne Information Enterprises, Inc. (the "Company") which have been
reserved for issuance under the Company's Restated Stock Option Plan Two (the
"Plan"). A total of 930,000 shares of the Common Stock reserved under the Plan
have previously been registered on a Registration Statement on Form S-8
(Registration No. 333-08279, filed on July 17, 1996) (the "Original Form S-8").
Pursuant to and as permitted by General Instruction E to Form S-8, the contents
of the Original Form S-8 are hereby incorporated by reference herein, and the
opinions and consents listed at Item 8 below are annexed hereto.

Item 8.           Exhibits.

         The following exhibits are filed as part of this Registration
Statement:

<TABLE>
<CAPTION>
         Exhibit
         Number   Description
         -------  -----------
         <S>      <C>
         5        Opinion of Troutman Sanders LLP.

         23.1     Consent of Troutman Sanders LLP (contained in opinion filed as
                  Exhibit 5).

         23.2     Consent of KPMG Peat Marwick LLP.

         24       Powers of Attorney (contained on page II-3 hereof).
</TABLE>


                                      II-2
<PAGE>   3


                                   SIGNATURES

         Pursuant to the requirements of the Securities Act of 1933, as amended,
the Registrant certifies that it has reasonable grounds to believe that it meets
all of the requirements for filing on Form S-8 and has duly caused this
Registration Statement to be signed on its behalf by the undersigned, thereunto
duly authorized, in the city of Atlanta, State of Georgia, on May 8, 1998.

                       HEALTHDYNE INFORMATION ENTERPRISES, INC.
                       (Registrant)

                       By:      /s/ Joseph G. Bleser
                          ------------------------------------------------------
                       Name:  Joseph G. Bleser
                       Title: Executive Vice President, Chief Financial Officer,
                              Secretary and Treasurer

         KNOW ALL MEN BY THESE PRESENTS, that each person whose signature
appears below hereby constitutes and appoints Robert I. Murrie and Joseph G.
Bleser, and each of them acting individually, as his true and lawful
attorneys-in-fact and agents, with full power of substitution and
resubstitution, for him and in his name, place and stead, and in any and all
capacities, to sign any and all amendments (including post-effective amendments)
to this Registration Statement, and to file the same, with all exhibits thereto,
and other documents in connection therewith, with the Securities and Exchange
Commission and any applicable securities exchange or securities self-regulatory
body, granting unto said attorneys-in-fact and agents, and each of them acting
individually, full power and authority to do and to perform each and every act
and thing requisite and necessary to be done in and about the premises, as fully
and to all intents and purposes as he might or could do in person, hereby
ratifying and confirming all that said attorneys-in-fact and agents, or any of
them acting individually, or their or his substitute or substitutes, may
lawfully do or cause to be done by virtue hereof.

         Pursuant to the requirements of the Securities Act of 1933, as amended,
this Registration Statement has been signed by the following persons in the
capacities and on the dates indicated.

<TABLE>
<CAPTION>
SIGNATURE                               TITLE                                                       DATE
- ---------                               -----                                                       ----
<S>                                     <C>                                                     <C>
/s/ Parker H. Petit                     Chairman of the Board of Directors                      May 8, 1998
- ---------------------------------
Parker H. Petit

/s/ Robert I. Murrie                    Director, President and Chief Executive Officer         May 8, 1998
- ---------------------------------       (Principal Executive Officer)
Robert I. Murrie                 
</TABLE>


                                      II-3
<PAGE>   4

<TABLE>
<CAPTION>
SIGNATURE                               TITLE                                                       DATE
- ---------                               -----                                                       ----
<S>                                     <C>                                                     <C>
/s/ Joseph G. Bleser                    Director, Executive Vice President-Finance,             May 8, 1998
- ---------------------------------       Chief Financial Officer, Treasurer and Secretary
Joseph G. Bleser                        (Principal Financial Officer)

/s/ Cheryl N. Blanco                    Vice President - Controller, Chief Accounting           May 8, 1998
- ---------------------------------       Officer, Assistant Treasurer and Assistant
Cheryl N. Blanco                        Secretary (Principal Accounting Officer)

/s/ J. Terry Dewberry                   Director                                                May 8, 1998
- ---------------------------------
J. Terry Dewberry

/s/ William J. Gresham, Jr.             Director                                                May 8, 1998
- ---------------------------------
William J. Gresham, Jr.

/s/ Charles R. Hatcher, Jr.             Director                                                May 6, 1998
- ---------------------------------
Charles R. Hatcher, Jr.

/s/ John W. Lawless                     Director                                                May 4, 1998
- ---------------------------------
John W. Lawless

/s/ Carl E. Sanders                     Director                                                May 8, 1998
- ---------------------------------
Carl E. Sanders

/s/ Donald W. Weber                     Director                                                May 8, 1998
- ---------------------------------
Donald W. Weber
</TABLE>


                                      II-4
<PAGE>   5

                                  EXHIBIT INDEX

<TABLE>
<CAPTION>
         Exhibit
         Number   Description
         -------  -----------
         <S>      <C>
         5        Opinion of Troutman Sanders LLP.

         23.1     Consent of Troutman Sanders LLP (contained in opinion filed as
                  Exhibit 5).

         23.2     Consent of KPMG Peat Marwick LLP.

         24       Powers of Attorney (contained on page II-3 hereof).
</TABLE>




<PAGE>   1


                                                                       EXHIBIT 5

                              Troutman Sanders LLP
                                NationsBank Plaza
                      600 Peachtree Street N.E., Suite 5200
                           Atlanta, Georgia 30308-2216
                            Telephone: (404) 885-3000
                            Facsimile: (404) 885-3995

                                   May 8, 1998

Healthdyne Information Enterprises, Inc.
1850 Parkway Place
Suite 1100
Marietta, Georgia  30067

Ladies and Gentlemen:

         We have examined a copy of the registration statement on Form S-8
proposed to be filed by Healthdyne Information Enterprises, Inc. (the
"Company"), with the Securities and Exchange Commission (the "Commission"),
relating to the registration pursuant to the provisions of the Securities Act of
1933, as amended (the "Act"), of 89,783 shares (the "Shares") of the Company's
Common Stock, par value $.01 per share, together with associated preferred stock
purchase rights (the "Common Stock"), reserved for issuance in connection with
options to be granted under the Company's Restated Stock Option Plan Two (the
"Plan"). In rendering this opinion, we have reviewed such documents and made
such investigations as we deemed appropriate.

         We are of the opinion that, subject to compliance with the pertinent
provisions of the Act and to compliance with such securities or "Blue Sky" laws
of any jurisdiction as may be applicable, when certificates evidencing the
Shares have been duly executed, countersigned, registered, issued and delivered
in accordance with the terms of the Plan and the respective stock option
agreements entered into, under and in accordance with the Plan, the Shares will
be duly and validly issued and outstanding, fully paid and non-assessable shares
of Common Stock of the Company.

         We are members of the Bar of the State of Georgia. In expressing the
opinions set forth above, we are not passing on the laws of any jurisdiction
other than the laws of the State of Georgia and the Federal law of the United
States of America.

         We hereby consent to the filing of this opinion or copies thereof as an
exhibit to the registration statement referred to above.

                                     Very truly yours,


                                     /s/ Troutman Sanders LLP



<PAGE>   1


                                                                    EXHIBIT 23.2


                         ACCOUNTANTS' CONSENT


The Board of Directors
Healthdyne Information Enterprises, Inc.

We consent to the use of our reports incorporated herein by reference.

                                             /s/ KPMG Peat Marwick LLP
                    
                                             KPMG PEAT MARWICK LLP

Atlanta, Georgia 
May 8, 1998


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission